Search alternatives:
significant reductions » significant reduction (Expand Search), significant predictors (Expand Search), significant variations (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reductions decrease » reduction decreased (Expand Search)
significant reductions » significant reduction (Expand Search), significant predictors (Expand Search), significant variations (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reductions decrease » reduction decreased (Expand Search)
-
1721
-
1722
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
1723
-
1724
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
1725
-
1726
-
1727
-
1728
-
1729
Transition probabilities and class sizes for three-step LTA model (N = 432).
Published 2025Subjects: -
1730
-
1731
-
1732
-
1733
-
1734
-
1735
-
1736
-
1737
ASP protects the AC16 cells from DOX-induced cardiotoxicity via Nrf2 activation.
Published 2025“…<p>(A) Representative images of protein expression detected by Western blot of p-PI3K,p-AKT, AKT, and the Nrf2 downstream signaling pathways in AC16 cells; (B, C) ML385 does not affect PI3K/AKT (n = 3); (D-F) The statistical results show that ML385 significantly represses NRF2 activation, leading to a decrease in its downstream gene expression (n = 3); (G, H) Lipid ROS levels (n = 3); (I, J) Quantitative q-PCR analysis of relative ANP and BNP mRNA expression (n = 3); (K, L) Representative images (Scale bar = 100 μm) and statistical analysis of JC-1 (n = 150); One-way ANOVA (Tukey post-test), means ± SD. …”
-
1738
-
1739
-
1740